March 8, 2024
The Ministry of Health, Labor and Welfare (MHLW) is asking pharma companies and other healthcare stakeholders to ensure “distribution at fair prices” for drugs that became subject to special re-pricing rules for unprofitability in the FY2024 NHI price revision. The...read more